九興控股(01836.HK)去年全年收入按年增長35.6%至15.4億美元
九興控股(01836.HK)公佈,截至去年12月31日止三個月,集團未經審覈綜合收入增長44.9%至約4.058億美元。去年全年,集團綜合收入增長35.6%至約15.406億美元,主要由於集團製造業務訂單持續回升。
另外,去年第四季及全年的出貨量分別按年增長33.3%及28.6%,主要由於集團所有產品類別訂單皆持續回升。平均售價於去年第四季及全年均有所上調,主要受集團客戶組合及產品組合的變化所致。
集團指,就即將到來的今年春季及夏季的訂單水平保持審慎樂觀態度,並將繼續密切監察潛在不利因素,包括東南亞及中國的疫情,並將採取措施把有關影響降致最低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.